Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

ESTUDIO DE FASE III, MULTICÉNTRICO, ALEATORIZADO, CON DOBLE ENMASCARAMIENTO, CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA, SEGURIDAD, FARMACOCINÉTICA Y FARMACODINAMIA DE SATRALIZUMAB EN PACIENTES CON ORBITOPATÍA TIROIDEA DE MODERADA A SEVERA

  • Protocol code: GP44729
  • EudraCT code: No aplica
  • Pathology: Malalties de l’ull i dels seus annexos
  • Principal investigator:  Arcediano Sánchez, Miguel Ángel
  • Research group:  Oftalmologia
  • Service: Oftalmologia
  • Phase: Fase III
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A 52-week randomized,double-blind, placebocontrolled, multi-center Phase 2b study with a 52-week blinded extension assessing safety and efficacy of frexalimab, a CD40L antagonist monoclonal antibody, for preservation of pancreatic ß-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy

  • Protocol code: DRI17476
  • EudraCT code: No aplica
  • Pathology: Malalties endocrines, nutricionals i metabòliques
  • Principal investigator:  Hernández Pascual, Cristina
  • Research group:  Diabetis i metabolisme
  • Service: Endocrinologia
  • Phase: Fase II
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de fase III, aleatorizado, doble ciego, controlado con placebo y motivado por los acontecimientos para demostrar la eficacia y seguridad de milvexian, un inhibidor oral del factor XIa, después de padecer un síndrome coronario agudo reciente

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A phase 3 multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of eneboparatide (AZP-3601), a parathyroid hormone receptor agonist, in patients with chronic hypoparathyroidism (CALYPSO)

  • Protocol code: AZP-3601-CLI-002
  • EudraCT code: _
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Rojano Toimil, Alba
  • Research group:  Diabetes and Metabolism
  • Service: Endocrinology
  • Phase: Phase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
Year
2024
Títol Complet
Servicio de un profesional en psicología para hacer avaluaciones neuropsicológicas y almacenamiento de datos, a cargo del proyecto PI22/01082 de la Unidad de Investigación en Neurotraumatología y Neurocirugía (UNINN), de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR)
Expedient
AVALUACIÓN NEUROPSICOLÓGICAS (PI22/01082)
Codi
24966227
Data publicació
Year
2024
Títol Complet
Contractació del subministrament i instal·lació de tres cambres frigorífiques del nou edifici de la Fundació Hospital Universitari Vall d’Hebron - Institut de Recerca (VHIR)
Expedient
CAMBRES FRIGORIFIQUES EDIFICI VHIR
Codi
24966297
Data publicació
Year
2024
Títol Complet
Acord Marc per a l'homologació de tres proveïdors per a dur a terme els serveis d'assessorament en Dret Administratiu, destinat a la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR).
Expedient
ASSES. DRET ADMINISTRATIU
Codi
24966014
Data publicació
Year
2024
Data d'inici
Data de tancament
Descripció
Experienced Project Manager – European Rare Blood disorders Registries_20240055
Codi
2024-55
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Clinical Researcher in Pediatric Endocrinology_20240052
Codi
2024-52
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Researcher Technician-Hepato-bilio-pancreatic surgery (HBP) and liver transplantation_20240053
Codi
2024-53
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Biostatistician_20240054
Codi
2024-54
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Licensed Technician (Pediatric Hepatology) - HBP surgery and liver transplantation_20240047
Codi
2024-47
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Research Technician_20240048
Codi
2024-48
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Service Assistant - Translational Molecular Pathology Group_20240049
Codi
2024-49
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Lab Technician Diabetes and Metabolism Research Group_20240050
Codi
2024-50
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Lab Technician Diabetes and Metabolism Research Group_20240051
Codi
2024-51
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Post-doctoral Researcher-Mental Health and Addictions Group_20240044
Codi
2024-44
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Senior Project Manager-Psychiatry, Mental Health and Addictions Research Group_20240045
Codi
2024-45
Reclutant
Inactiu